Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt...
Read moreDetailsWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read moreDetailsCOR completes the acquisition of Retina Consultants of America, marking a significant step in expanding its specialty healthcare and MSO...
Read moreDetailsCencora (COR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This...
Read moreDetailsWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top...
Read moreDetailsWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top...
Read moreDetailsInvestors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately.
Read moreDetailsThis website automatically aggregates content from various other websites. The copyright of content and images belongs to those websites and their respective companies. We are not responsible for the content published here. Please ensure that all information is for reference only and not investment advice. However, we will strive to strictly control content that provides no value or brings negativity to the community.
© 2025 financialat.com